| TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals (NCT05275998) | TaiMed Biologics Inc. | 2022-07-05 |
| HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia (NCT05652400) | Lund University | 2022-07-01 |
| Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV (NCT05330143) | Ascletis Pharmaceuticals Co., Ltd. | 2022-06-28 |
| Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV (NCT04174755) | University College Dublin | 2022-06-22 |
| A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02) (NCT04120415) | ANRS, Emerging Infectious Diseases | 2022-06-21 |
| Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study (NCT05220358) | Orlando Immunology Center | 2022-06-15 |
| Study of VRC07-523LS, CAP256V2LS, and Vesatolimod, in Early Antiretroviral-treated HIV-1 Clade C-infected Women (NCT05281510) | Gilead Sciences | 2022-06-09 |
| Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US (NCT05129345) | Duke University | 2022-06-07 |
| Alternative Viral Load Tests During Start of Antiretroviral Therapy (NCT05418790) | Luis Montaner | 2022-06-01 |
| Thetha Nami Ngithethe Nawe ("Let's Talk"): Step Wedge cRCT of Peer Led Community PrEP and SRH for Youth in South Africa (NCT05405582) | Africa Health Research Institute | 2022-05-26 |
| A Real-world Study of Lamivudine and Dotiravir Sodium Tablets in the Treatment-naïve HIV-1 Infected Patients (NCT05332470) | Peking Union Medical College Hospital | 2022-05-01 |
| Expedited Partner Therapy and the HIV Prevention Cascade (NCT04553211) | University of California, Los Angeles | 2022-04-25 |
| Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression (NCT04738812) | ANRS, Emerging Infectious Diseases | 2022-04-21 |
| The Visceral Adiposity Measurement and Observation Study (NCT05383456) | Theratechnologies | 2022-04-18 |
| Resistance Profile to Antiretroviral Medications in Individuals Living With HIV Who Failed a First-Line Regimen With Tenofovir / Lamivudina and Dolutegravir in Brasil (NCT07618507) | Federal University of São Paulo | 2022-04-13 |
| Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects (NCT05165550) | Viriom | 2022-04-12 |
| Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P) (NCT03834909) | Johns Hopkins University | 2022-04-01 |
| Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy (NCT05204394) | Viriom | 2022-04-01 |
| HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV (NCT05481216) | NEAT ID Foundation | 2022-03-29 |
| Implementing Cabenuva in Arkansas HIV Programs (NCT05096949) | University of Arkansas | 2022-03-07 |
| Uganda PrEP and Harm Reduction Evaluation (NCT05040308) | University of Washington | 2022-02-11 |
| BFTAF Elderly Switch Study (NCT05243602) | University of Nairobi | 2022-02-01 |
| Longer-Acting PrEP in Transgender and Gender Diverse Texans (NCT05044286) | University of Texas at Austin | 2022-02-01 |
| HIV-Infected Latin American Asylum Seekers in Europe: Insights From the EuroLatin HIV Cohort (NCT05998499) | Hospital Universitario Infanta Leonor | 2022-01-30 |
| Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART (NCT05144386) | Excision BioTherapeutics | 2022-01-24 |
| BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection: (NCT05004038) | University of Zurich | 2022-01-04 |
| A Proof-of-concept Trial to Evaluate the Safety and Efficacy of UB-421 Plus Chidamide in Changing HIV Reservoirs (NCT05056974) | United BioPharma | 2021-12-02 |
| HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia (NCT06127290) | Euresist Network GEIE | 2021-12-01 |
| Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV (NCT05052996) | Gilead Sciences | 2021-10-05 |
| Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033) (NCT04776252) | Merck Sharp & Dohme LLC | 2021-09-15 |
| Impact of V106I on Resistance to Doravirine (NCT04894357) | Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental | 2021-09-01 |
| Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder (NCT04963712) | Shanghai Public Health Clinical Center | 2021-09-01 |
| Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART) (NCT04388904) | The Crofoot Research Center, Inc. | 2021-09-01 |
| A Study to Test Three Experimental HIV Vaccines in Healthy Adults. (NCT04553016) | University of Oxford | 2021-08-16 |
| 2000HIV Trained Innate Immunity in HIV Elite Controllers (NCT04968717) | Radboud University Medical Center | 2021-08-02 |
| Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60 mg/5 mg/30 mg) (NCT05030025) | Mylan Inc. | 2021-08-01 |
| DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV: (NCT04884139) | Fundacion SEIMC-GESIDA | 2021-07-14 |
| Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection (NCT04296695) | Peking Union Medical College Hospital | 2021-07-14 |
| Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age (NCT05147740) | Tulika Singh, MD | 2021-07-01 |
| Impact of Rapid ART Initiation on Retention in Care in the Southern US (NCT04266938) | University of Louisville | 2021-06-01 |
| A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the Netherlands (NCT04888754) | Erasmus Medical Center | 2021-05-26 |
| Acute Neural and Immune Effects of Alcohol in People Living With HIV Infection (NCT04050735) | Brown University | 2021-05-19 |
| Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3 (NCT04880395) | Fundación Huésped | 2021-05-17 |
| SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort (NCT05067400) | Royal Free Hospital NHS Foundation Trust | 2021-04-21 |
| ANRS 12406 EvvA Study (NCT04593979) | ANRS, Emerging Infectious Diseases | 2021-04-15 |
| InTSHA: Interactive Transition Support for HIV-infected Adolescents Using Social Media (NCT03624413) | Emory University | 2021-04-15 |
| Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. (NCT04860063) | Hospital Civil de Guadalajara | 2021-04-01 |
| D²EFT Graphical Informed Consent (NCT04668443) | Kirby Institute | 2021-03-22 |
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ，Pharmacodynamics of Oral SHR2150 in Healthy Subjects (NCT04802811) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-22 |
| Contingency Management for PrEP Adherence and/or Methamphetamine Use (NCT04563962) | University of California, Los Angeles | 2021-03-15 |
| Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV (NCT04661813) | Case Western Reserve University | 2021-03-01 |
| Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV (NCT04255849) | Weill Medical College of Cornell University | 2021-02-23 |
| ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI Resistance (NCT04429152) | Professor Francois Venter | 2021-02-09 |
| Simplifying Treatment and Monitoring for HIV (STREAM HIV) (NCT04341779) | University of Washington | 2021-02-04 |
| An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers (NCT05148754) | Viriom | 2021-01-23 |
| Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis). (NCT04526977) | Asociacion para el Estudio de las Enfermedades Infecciosas | 2021-01-10 |
| DORA: A Doravirine-based First-line Antiretroviral Therapy for Women of Reproductive Potential Living With HIV (NCT04433780) | Professor Francois Venter | 2021-01-04 |
| Effect of Methamphetamine on Residual Latent HIV Disease Study (NCT03825536) | University of California, San Francisco | 2021-01-01 |
| Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation Administered in HIV-1 Infected Treatment Naive Patients (NCT04620304) | United BioPharma | 2021-01-01 |
| HIV Drug Resistance Pattern Due to Migration in Poland (NCT04636736) | Medical University of Warsaw | 2021-01-01 |
| The Benefits of Immediate Treatment Initiation Without Immunovirological Data Compared to Conventional BIC / FTC / TAF Treatment in Naive Patients With Type 1 HIV (Human Immunodeficiency Virus) Infection (NCT05606055) | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 2020-12-01 |
| Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028) (NCT04295772) | Merck Sharp & Dohme LLC | 2020-11-26 |
| Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test (NCT04549467) | Fundacion IDEAA | 2020-11-17 |
| Pharmacokinetics of Single-dose Dolutegravir in HIV-seronegative Subjects With Severe Hepatic Impairment Compared to Matched Controls. (NCT03813979) | Radboud University Medical Center | 2020-11-15 |
| Poor Sleep and Inflammation in HIV-Infected Adults (NCT03848325) | University of Pittsburgh | 2020-11-09 |
| Postpartum Pre-exposure Prophylaxis (PrEP) Study to Evaluate an Adherence Promotion Package for Postpartum Women on PrEP (NCT04897737) | University of California, Los Angeles | 2020-11-05 |
| Explorations Into the Mechanism for INSTI-associated Weight Gain: a Focus on Energy Balance (NCT04495348) | University of Colorado, Denver | 2020-10-22 |
| Islatravir and Methadone Pharmacokinetics (MK-8591-029) (NCT04568603) | Merck Sharp & Dohme LLC | 2020-10-16 |
| A Test and Treat Strategy in New HIV Diagnosis. (NCT04416906) | Judit Pich Martínez | 2020-10-05 |
| Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment (NCT03940521) | Centre Hospitalier Universitaire de Nīmes | 2020-09-30 |
| ANRS 12372 MODERATO Study (NCT04022967) | ANRS, Emerging Infectious Diseases | 2020-09-21 |
| Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes (NCT04770701) | Trieu, Nguyen Thi, M.D. | 2020-09-20 |
| Contribution of Dolutegravir to Obesity and Cardiovascular Disease (NCT04340388) | Augusta University | 2020-09-17 |
| Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD (NCT04311944) | Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic | 2020-09-01 |
| Impact of M184V on the Virological Efficacy to 3TC/DTG (LAMRES) (NCT04568239) | Association de Recherche en Virologie et Dermatologie | 2020-09-01 |
| Telemedicine in HIV Care in Buenos Aires (NCT04513496) | Fundacion Ibis | 2020-09-01 |
| Call for Life Youth ART Adherence Study (NCT04718974) | Makerere University | 2020-08-12 |
| More Than a Machine: Make Point-of-care HIV-1 Viral Load Testing Effective in Rural Uganda (NCT04517825) | University of North Carolina, Chapel Hill | 2020-08-08 |
| Bictegravir in the Elderly Living With HIV (BICEP) (NCT05064020) | State University of New York at Buffalo | 2020-08-01 |
| Euphorbia Kansui and HIV/AIDS Functional Cure (NCT04503928) | Shanghai Public Health Clinical Center | 2020-08-01 |
| Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA Reverse Transcriptase Clearance During Effective Antiretroviral Therapy (NCT04448158) | Association de Recherche en Virologie et Dermatologie | 2020-07-01 |
| Epidemiological and Clinical Description of Women Living With HIV in Selected Countries of Latin America (NCT04605354) | Helios Salud | 2020-07-01 |
| Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2) (NCT03588715) | Luis Montaner | 2020-06-18 |
| REal-Life Cohort With DOlutegravir + LAmivudina (NCT04638686) | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 2020-06-15 |
| Study to Assess the Safety and Durability of Viral Control Beyond 24 Weeks of Analytical Treatment Interruption After the Administration of Candidate HIV-1 Vaccines DNA.HTI, MVA.HTI and ChAdOx1.HTI or Placebo in Early Treated HIV-1 Positive Individuals (ATI Extension of AELIX-002 Study) (NCT04385875) | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2020-06-01 |
| 2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial (NCT04553081) | University Hospital, Ghent | 2020-05-26 |
| Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) (NCT04354818) | Kirby Institute | 2020-05-11 |
| the Study to Evaluate the Safety of UB-421 in Combination With Antiretroviral Therapy (ART) and the Efficacy in Reduction of HIV Viral Load and Proviral DNA as Compared to ART Alone in ART-experienced Viremic HIV-1 Patients (NCT04041362) | United BioPharma | 2020-04-01 |
| Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019) (NCT04233216) | Merck Sharp & Dohme LLC | 2020-03-18 |
| Cellular Pharmacology and Platelet Effects of Abacavir and Lamivudine Anabolites (NCT04301661) | University of Colorado, Denver | 2020-03-06 |
| Genotype-Informed Versus Empiric Management of VirEmia (NCT04233242) | Swiss Tropical & Public Health Institute | 2020-03-03 |
| An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women (NCT04330989) | University of North Carolina, Chapel Hill | 2020-03-01 |
| Short Cycle Therapy in ART Regimens Containing Rilpivirine: Assessment of Patients' Satisfaction (NCT04281459) | Azienda Ospedaliera Universitaria Integrata Verona | 2020-03-01 |
| Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals (NCT04079452) | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2020-02-18 |
| Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals (NCT04097925) | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2020-02-18 |
| Second-line Switch to Dolutegravir Study (NCT04229290) | University of Nairobi | 2020-02-12 |
| Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone (NCT04133012) | ANRS, Emerging Infectious Diseases | 2020-02-10 |
| Dolutegravir in Real Life in Lesotho (NCT04238767) | Swiss Tropical & Public Health Institute | 2020-02-10 |
| Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based Regimen (NCT04155554) | Azienda Ospedaliera Universitaria Senese | 2020-01-29 |
| Bictegravir/Emtricitabine/Tenofovir Alafenide Plus Doravirine (NCT04538040) | Quest Clinical Research | 2019-12-19 |